Methods: A comprehensive literature search was performed across multiple medical databases, including Embase, Medline, and Cochrane to look for English articles on interventions with SGLT2 inhibitors, GLP-1, and dual gastric inhibitory polypeptide/GLP-1 receptor agonists in people living with sleep apnea and overweight or obesity
Eli Lillys diabetes drug, tirzepatide, also known as Mounjaro, is expected to be approved by the FDA for weight loss in 2023
Alcohol Several studies investigating exendin-4, liraglutide, dulaglutide and semaglutide in rats and mice found a decrease in alcohol use, which was mediated by mesolimbic dopamine pathways involving the nucleus accumbens, the ventral tegmental area and the ventral hippocampus, the dorso-lateral septum, and the nucleus of the solitary tract 59,60,61,63,64,65,66,67,68,69,72,74,75,76,77,79,80,81,82,106
These drugs were originally intended to stimulate insulin production, reducing blood sugar levels and serving as an effective treatment for type-2 diabetes
and Others GLP-1 market is segmented by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type of Agonist, Route of Administration, Target Indication, Dosing Frequency, Delivery System and Payer are the key segment of GLP-1 Market
Hedonic hunger: a new dimension of appetite
